AstraZeneca PLC
AZN· NYSE
AZNAstraZeneca PLC
Source filing unavailable
| Metric | Q2 2023 | Q2 2022 | Q2 2021 | Q2 2020 |
|---|---|---|---|---|
| Revenue | $11.42B | $10.77B | $8.22B | $6.28B |
| Net Income | $1.82B | $360.00M | $550.00M | $756.00M |
| EPS Diluted | $1.17 | $0.23 | $0.42 | $0.58 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
AstraZeneca PLC · CIK 901832 · Engraved from SEC EDGAR
